A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol describes a novel method for creating 3D midbrain organoids from human induced pluripotent stem cells, guiding their formation to mimic native midbrain tissue, thereby aiding in the study of development and disorders.
The development of midbrain organoids (MOs) from human pluripotent stem cells (hPSCs) represents a significant advancement in understanding brain development, facilitating precise disease modeling, and advancing therapeutic research. This protocol outlines a method for generating midbrain-specific organoids using induced pluripotent stem cells (iPSCs), employing a strategic differentiation approach. Key techniques include dual-SMAD inhibition to suppress SMAD signaling, administration of fibroblast growth factor 8b (FGF-8b), and activation of the Sonic Hedgehog pathway using the agonist purmorphamine, guiding iPSCs towards a midbrain fate.
The organoids produced by this method achieve diameters up to 2 mm and incorporate a diverse array of neuroepithelial cell types, reflecting the midbrain's inherent cellular diversity. Validation of these organoids as authentic midbrain structures involves the expression of midbrain-specific markers, confirming their identity. A notable outcome of this methodology is the effective differentiation of iPSCs into dopaminergic neurons, which are characteristic of the midbrain.
The significance of this protocol lies in its ability to produce functionally mature, midbrain-specific organoids that closely replicate essential aspects of the midbrain, offering a valuable model for in-depth exploration of midbrain developmental processes and the pathophysiology of related disorders such as Parkinson's disease. Thus, this protocol serves as a crucial resource for researchers seeking to enhance our understanding of the human brain and develop new treatments for neurodegenerative diseases, making it an indispensable tool in the field of neurological research.
The human brain, with its intricate architecture and complex cellular and molecular composition, presents formidable challenges in neuroscience research, particularly in the context of disease modeling and cellular therapy development1. These challenges are further complicated by the limited availability of sophisticated in vitro models that truly represent the complexity of the human brain. However, recent advancements in human induced pluripotent stem cell (iPSC) technology, enabling controlled differentiation into specific neuronal subtypes, have opened promising avenues for exploring human brain development, disease pathogenesis, and cell-b....
The iPSCs generated from human normal fibroblasts Detroit 551 and human embryonic stem cells (ESCs) hESC line 360 as previously described4. The iPSCs were obtained with the approval of the Western Norway Committee for Ethical Health Research REK nr. 2012/919. All cells were regularly monitored for Mycoplasma contamination using MycoAlert Mycoplasma Detection Kit. The Table of Materials contains information about all materials, reagents, and equipment used in this protocol. Table 1 describes the media and other stock used.
1. Thawing of iPSCs
In this study, we introduce a pioneering protocol for the derivation of MOs from iPSCs. Central to our methodology is the innovative use of dual-SMAD inhibition, synergistically combined with FGF-8b and sonic hedgehog (SHH) pathway agonist purmorphamine (PM). This approach is depicted in Figure 1. The differentiation process begins by steering iPSCs towards neuroectoderm lineage, forming neuroepithelial or neural rosette colonies. This is achieved through dual SMAD signaling inhibition, empl.......
In this investigation, we have developed a methodology for the differentiation of MO from iPSCs. Our protocol employs a dual-SMAD inhibition strategy enhanced with morphogenic factors, including FGF-8b and the SHH agonist PM. This approach closely simulates the developmental cues crucial for midbrain ontogeny. The differentiation pathway we have instituted prompts the formation of neuroepithelial structures reminiscent of neural rosettes observed during natural brain development. This transformation from bidimensional cu.......
The authors have no conflicts of interest to disclose.
Figure 1 is created using BioRender.com. We thank University of Bergen Meltzers Høyskolefonds (project number: 103517133), Gerda Meyer Nyquist Guldbrandson, and Gerdt Meyer Nyquists legat (project number: 103816102) for funding.
....Name | Company | Catalog Number | Comments |
CCD Microscope Camera Leica DFC3000 G | Leica Microsystems, Germany | ||
Chemically Defined Lipid Concentrate | Thermo Fisher Scientific | 11905031 | CDM ingredient |
Collagenase IV | Thermo Fisher Scientific | 17104019 | Reagent for gentle dissociation of human iPSCs |
Corning non-treated culture dishes | Sigma-Aldrich | CLS430589 | Suspension culture |
DMEM/F-12, GlutaMAX supplement | Thermo Fisher Scientific | 10565018 | Astrocyte differentiation basal Medium |
DPBS | Thermo Fisher Scientific | 14190250 | Used for a variety of cell culture wash |
EDTA | Thermo Fisher Scientific | 15575020 | Reagent for gentle dissociation of human iPSCs |
Essential 8 Basal Medium | Thermo Fisher Scientific | A1516901 | Basal medium for iPSC culture |
Essential 8 Supplement (50x) | Thermo Fisher Scientific | A1517101 | Supplement for iPSC culture |
FCCP | Abcam | ab120081 | Eliminates mitochondrial membrane potential and TMRE staining |
FGF-basic | PeproTech | 100-18B | Astrocyte differentiation medium ingredient |
Fluid aspiration system BVC control | Vacuubrand, Germany | ||
Formaldehyde (PFA) 16% | Thermo Fisher Scientific | 28908 | Cell fixation |
GDNF | Peprotech | 450-10 | DA neurons medium ingredient |
Geltrex (Basement membrane matrix) | Thermo Fisher Scientific | A1413302 | Used for attachment and maintenance of human iPSCs |
GlutaMAX Supplement | Thermo Fisher Scientific | 35050061 | Supplement for NSC culture |
Heracell 150i CO2 Incubators | Fisher Scientific, USA | ||
IMDM | Thermo Fisher Scientific | 21980032 | Basal medium for CDM |
InSolution AMPK Inhibitor | Sigma-Aldrich | 171261 | Neural induction medium ingredient |
Insulin | Roche | 1376497 | CDM ingredient |
iPSCs derived from Detroit 551 fibroblats | ATCC | CCL-110 | |
Leica TCS SP8 STED confocal microscope | Leica Microsystems, Germany | ||
Matrigel | Life Science | 354230 | Matrigel embedding |
Monothioglycerol | Sigma-Aldrich | M6145 | CDM ingredient |
Normal goat serum | Thermo Fisher Scientific | PCN5000 | Used for blocking buffer |
Orbital shakers - SSM1 | Stuart Equipment, UK | ||
Organoid Embedding Sheet | STEMCELL Technologies | 8579 | Matrigel embedding |
Organoid Embedding Sheet | STEMCELL Technologies | 8579 | |
PBS 1x | Thermo Fisher Scientific | 18912014 | Used for a variety of washes |
Poly-D-lysine hydrobromide | Sigma-Aldrich | P7405 | Promotes attachment and growth of neural cells in vitro |
Poly-L-ornithine solution | Sigma-Aldrich | P4957 | Promotes attachment and growth of neural cells in vitro |
ProLong Gold Antifade Mountant | Thermo Fisher Scientific | P36930 | Mounting the coverslip for confocal image |
Purmorphamine | STEMCELL Technologies | 72204 | Promotes DA neuron differentiation |
Recombinant Human/Mouse FGF-8b Protein | R&D Systems | 423-F8-025/CF | Promotes DA neuron differentiation |
SB 431542 | Tocris Bioscience | TB1614-GMP | Neural Induction Medium ingredient |
TRITON X-100 | VWR International | 9002-93-1 | Used for cells permeabilization in immunostaining assays |
SSM1 compact orbital shaker | Norrscope | 51901-10 SSM1 Shaker, orbital, mini 230V | Rotator for organoid culturing. |
Water Bath Jb Academy Basic Jba5 JBA5 Grant Instruments | Grant Instruments, USA | ||
Antibodies used for immunostaining | |||
Primary antibody | |||
anti-DAT | Abcam | ab128848, RRID:AB_2665470 | Rabbit; 1:100 |
anti-FOXA2 | ProteinTech | 22474-1-AP, RRID:AB_2879110 | Rabbit; 1:100 |
anti-FOXG1 | Abcam | ab196868, RRID:AB_2892604 | Rabbit; 1:200 |
anti-LMX1 | Abcam | ab139726, RRID:AB_2827684 | Rabbit; 1:100 |
anti-MAP2 | Abcam | ab5392 ,RRID:AB_2138153 | Chicken; 1:500 |
anti-OTX2 | ProteinTech | 13497-1-AP, RRID:AB_2157176 | Rabbit; 1:100 |
anti-TH | Abcam | ab75875, RRID:AB_1310786 | Rabbit; 1:100 |
Secondary antibody | Dilution (μL) | ||
Alexa Fluor 594 goat anti-rabbit IgG | Thermo Fisher Scientific | A-11012 | 1:400 |
Alexa Fluor 488 goat anti-rabbit IgG | Thermo Fisher Scientific | A- 11008 | 1:400 |
Alexa Fluor 488 goat anti-rabbit IgG | Thermo Fisher Scientific | A- 11008 | 1:400 |
Alexa Fluor 488 goat anti-rabbit IgG | Thermo Fisher Scientific | A- 11008 | 1:400 |
Alexa Fluor 594 goat anti-rabbit IgG | Thermo Fisher Scientific | A-11012 | 1:400 |
Alexa Fluor 594 goat anti-rabbit IgG | Thermo Fisher Scientific | A-11012 | 1:400 |
Alexa Fluor 647 goat anti-chicken IgG | Thermo Fisher Scientific | A-21469 | 1:400 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved